Cruse Michael's Form 4 filing
OnKure Therapeutics, Inc. (OKUR) · filed Aug 31, 2022
- Accession no.
- 0001209191-22-048167
- Filed
- Aug 31, 2022
- Trade date
- Aug 29-31, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market purchases total $23.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cruse MichaelCIK 0001854179 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 29, 2022 | Common Stock | PPurchaseAcquired | +83 | $3.24 | +$268.92 | 30,783 | Direct | |
| Aug 29, 2022 | Common Stock | PPurchaseAcquired | +1,140 | $3.24 | +$3,693.6 | 1,140 | Indirect | |
| Aug 30, 2022 | Common Stock | PPurchaseAcquired | +975 | $3.16 | +$3,081 | 31,758 | Direct | |
| Aug 30, 2022 | Common Stock | PPurchaseAcquired | +1,845 | $3.19 | +$5,885.55 | 2,985 | Indirect | |
| Aug 31, 2022 | Common Stock | PPurchaseAcquired | +3,212 | $3.21 | +$10,310.52 | 6,197 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.